-
Companies that treat opioid use disorder could commend themselves last month when the federal government reported overdose deaths were down nearly 11% for the first eight months of 2024, marking the second-straight year of decline. “It’s fantastic news,” Jason Kletter, president of BayMark Health Services, told Addiction Treatment Business. “It’s something to celebrate.” But the […]
-
Acadia Healthcare Acquires 3 Facilities, Boosts Opioid Treatment Business
By Morgan Gonzales| October 15, 2024Acadia Healthcare (Nasdaq: ACHC) is executing its M&A strategy as it seeks to grow its geographic footprint. The largest behavioral health provider in the U.S. announced Tuesday that it acquired three opioid treatment programs (OTPs) in South Carolina, representing the company’s debut in the state’s opioid treatment landscape. “South Carolina is an underserved market with […]
-
One of California’s largest opioid treatment providers (OTP) is taking advantage of a landmark change in federal rules. Pinnacle Treatment Centers announced Monday that they will begin prescribing opioid use disorder (OUD) patients methadone via audio-visual telehealth sessions in the state of California. “Expanding access to methadone by allowing patients to initiate treatment via telehealth […]
-
Ashley Addiction Treatment Expands to Non-Addiction Mental Health Care
By Matthew Blake| October 9, 2024A 45-year-old Maryland addiction treatment provider has radically expanded its services. Ashley Addiction Treatment announced that as of Oct. 1 it is providing telehealth mental health services for all Maryland residents, regardless of whether the patient has a substance use disorder (SUD) diagnosis. Ashley, a nonprofit organization that is headquartered in Havre de Grace, Maryland, […]
-
The substance use disorder (SUD) treatment industry has a history as a scattered network of small cash-pay providers. It remains largely fragmented. Delray Beach, Florida-based Guardian Recovery has experience evolving from a founder-led, boutique provider to an expansive network of 17 physical facilities and virtual care options. The challenge for the provider now is to […]
-
Value-Based SUD Company Eleanor Health Raises $30M
By Matthew Blake| October 7, 2024Eleanor Health, a company that offers “addiction treatment from the comfort of home” announced Monday that it has raised $30 million in its latest equity financing round. The Series D capital raise was led by General Catalyst, a multinational venture-capital firm that previously led Eleanor Health’s $50 million Series C funding round. General Catalyst’s wide-ranging […]
-
Ophelia’s Playbook: How to Scale Medicaid OUD Treatment
By Morgan Gonzales| October 2, 2024Opioid use disorder (OUD) disproportionately impacts Medicaid beneficiaries, yet structural barriers – including lack of available clinicians – often keep this population from receiving treatment. Virtual OUD treatment provider Ophelia has expanded its Medicaid reach by inking new reimbursement contracts that cover the lives of 3 million New Jersey residents. “We’ve been live and treating […]
-
Comprehensive care models are becoming a key focus for behavioral health providers. Workforce behavioral health provider Lyra is expanding its substance use disorder (SUD) offerings by launching treatment programs for cannabis, opioids, stimulants and nicotine. The company announced the expansion on Monday. “Oftentimes, [treatment options for SUD] lack integrated, evidence-based care that addresses mental health […]
-
Behind the Glamour: Why Luxury Rehab Centers Have Lost Their Appeal
By Matthew Blake| October 1, 2024Tikvah Lake Recovery changed for the better when it “got rid of the 20 year olds on their phones,” according to Adam Nesenoff. Nesenoff has co-owed Tikvah Lake with his father, David Nesenoff, since 2016. It is a residential addiction treatment center in Sebring, Florida. More specifically, it is a self-described luxury rehabilitation center, charging […]
-
OIG Audit Reveals Gaps in Opioid Medication Access
By Matthew Blake| September 26, 2024A federal audit released last week found that, despite changes in the law, Medicare and Medicaid enrollees may not have access to medications for opioid use disorder (OUD). In assessing why swaths of the country have spotty or nonexistent access to the federally approved medications methadone and buprenorphine, the U.S. Department of Health and Human […]